Kayne Anderson Rudnick Investment Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $524 | Buy |
+19
| New | +$524 | ﹤0.01% | 988 |
|
|
2024
Q4 | – | Sell |
-21,719
| Closed | -$1.45M | – | 1016 |
|
|
2024
Q3 | $1.45M | Sell |
21,719
-654
| -3% | -$43.7K | ﹤0.01% | 365 |
|
|
2024
Q2 | $2.66M | Sell |
22,373
-503
| -2% | -$59.7K | 0.01% | 315 |
|
|
2024
Q1 | $2.44M | Sell |
22,876
-822
| -3% | -$87.6K | 0.01% | 321 |
|
|
2023
Q4 | $2.36M | Sell |
23,698
-1,022
| -4% | -$102K | 0.01% | 327 |
|
|
2023
Q3 | $2.55M | Sell |
24,720
-186
| -0.7% | -$19.2K | 0.01% | 329 |
|
|
2023
Q2 | $3.03M | Sell |
24,906
-374
| -1% | -$45.4K | 0.01% | 323 |
|
|
2023
Q1 | $3.88M | Hold |
25,280
| – | – | 0.01% | 308 |
|
|
2022
Q4 | $4.54M | Sell |
25,280
-1,070
| -4% | -$192K | 0.01% | 301 |
|
|
2022
Q3 | $3.12M | Buy |
+26,350
| New | +$3.12M | 0.01% | 311 |
|
|
2022
Q2 | – | Sell |
-6
| Closed | -$1K | – | 653 |
|
|
2022
Q1 | $1K | Buy |
6
+1
| +20% | +$167 | ﹤0.01% | 638 |
|
|
2021
Q4 | $1K | Buy |
+5
| New | +$1K | ﹤0.01% | 619 |
|